The 20 analysts offering 12-month price forecasts for Regeneron Pharmaceuticals Inc have a median target of 707.50, with a high estimate of 790.00 and a low estimate of 565.00. The median estimate represents a +3.10% increase from the last price of 686.23.
The current consensus among 24 polled investment analysts is to Buy stock in Regeneron Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $10.17
Reporting Date Aug 04
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.